Bayer Aktiengesellschaft (WSE:BAY)
88.53
-1.01 (-1.13%)
Apr 3, 2025, 9:05 AM CET
Bayer Aktiengesellschaft Revenue
In the year 2024, Bayer Aktiengesellschaft had annual revenue of 46.61B EUR, down -2.16%. Bayer Aktiengesellschaft had revenue of 11.73B in the quarter ending December 31, 2024, a decrease of -1.12%.
Revenue
46.61B EUR
Revenue Growth
-2.16%
P/S Ratio
n/a
Revenue / Employee
514.49K EUR
Employees
90,587
Market Cap
87.73B PLN
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 46.61B | -1.03B | -2.16% |
Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
NEUCA | 12.61B |
Synektik Spólka Akcyjna | 556.63M |
Voxel | 492.41M |
Celon Pharma | 209.54M |
Selvita | 345.76M |
Ryvu Therapeutics | 101.96M |
Centrum Medyczne ENEL-MED | 680.32M |
Scope Fluidics | 119.00K |